Restenosis Prevention

Stents have dramatically reduced the incidence of stenosis following percutaneous angioplasty. However, they are also known to restenose within months. Prevention of restenosis therefore depends on several factors:

  • Accurate stent placement and expansion, which avoids the occurrence of empty spaces for scar buildup
  • Use of targeted treatments to reduce neointimal hyperplasia and restenosis, which include:
    • Drug-eluting stents
    • Perivascular delivery which delivers the drug into the space around the artery
    • Delivery catheters
    • Antibody or peptide-linked drugs
    • Gene-based therapies
    • Cell-based therapies
    • Nanoparticle-based drug delivery
  • Lifestyle modifications as advised by the cardiologist, including regular exercise, lowering of blood pressure, quitting smoking and cutting down to one drink of alcohol, and a low-fat diet.
  • Use of appropriate medication to prevent platelet clots from forming

There are several categories of drugs for restenosis:

  • Drugs which inhibit coagulation, such as anticoagulants, antithrombotic agents and antiplatelet agents like clopidogrel and heparin
  • Anti-inflammatory agents such as dexamethasone and tranilast
  • Drugs which inhibit proliferation and oppose growth factors, such as ACE inhibitors, trapidil, tyrphostin
  • Cytostatic drugs which inhibit cell growth, like paclitaxel and rapamycin
  • Lipid-lowering agents such as statins
  • Antioxidants such as probucol or resveratrol

Vascular brachytherapy

Vascular brachytherapy is another technique used to prevent or treat a restenotic lesion. Here short-range ionizing therapy is used to inhibit neointimal hyperplasia, so as to prevent shrinkage of the arterial lumen after angioplasty. The radiation produces:

  • Inhibition of smooth muscle cell proliferation
  • Increased number of cells that enter the apoptosis pathway
  • Less fibrosis
  • Less negative remodeling, or healing which results in a shrunken lumen

Characteristic changes in irradiated vessels include:

  • Persistent absence of endothelium over the irradiated part of the vessel
  • Fibrin deposition over the bare area
  • Inflammatory cell infiltration of the vessel wall

Vascular brachytherapy can be used alone or following angioplasty of a restenotic lesion. This is performed through a special catheter placed for 10 minutes inside the blocked segment, and containing a source of short-term radiation.

References

Further Reading

Last Updated: Aug 23, 2018

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2018, August 23). Restenosis Prevention. News-Medical. Retrieved on October 16, 2019 from https://www.news-medical.net/health/Restenosis-Prevention.aspx.

  • MLA

    Thomas, Liji. "Restenosis Prevention". News-Medical. 16 October 2019. <https://www.news-medical.net/health/Restenosis-Prevention.aspx>.

  • Chicago

    Thomas, Liji. "Restenosis Prevention". News-Medical. https://www.news-medical.net/health/Restenosis-Prevention.aspx. (accessed October 16, 2019).

  • Harvard

    Thomas, Liji. 2018. Restenosis Prevention. News-Medical, viewed 16 October 2019, https://www.news-medical.net/health/Restenosis-Prevention.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post